Effect of Supine or Prone Position After Caesarean Birth
1 other identifier
interventional
65
1 country
1
Brief Summary
Respiratory Distress is a frequent clinical diagnosis of babies delivered by elective Caesarean birth. There has been no study comparing the efficacy of immediately positioning a newly born infant prone vs. supine for the first 30 60 seconds of life after delivery by Caesarean birth.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2006
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2009
CompletedFirst Submitted
Initial submission to the registry
March 4, 2011
CompletedFirst Posted
Study publicly available on registry
March 8, 2011
CompletedAugust 31, 2018
August 1, 2018
2.4 years
March 4, 2011
August 29, 2018
Conditions
Study Arms (2)
Prone Positioning
ACTIVE COMPARATORNewly born infant placed in prone position (face up) for the first 30 60 seconds of life after delivery by Cesarean birth.
Supine Positioning
ACTIVE COMPARATORnewly born infant placed in supine position (face down) for the first 30 60 seconds of life after delivery by Cesarean birth.
Interventions
Eligibility Criteria
You may qualify if:
- \* Any woman not in labor who are undergoing elective Cesarean birth at term, 37 to 41 completed weeks gestation.
You may not qualify if:
- any woman with prior rupture of membranes
- diabetes mellitus, gestational diabetes,
- any woman receiving sedation
- using medication such as Demerol, magnesium sulfate or general anesthesia
- any woman who has a known drug history
- any known macrosomia
- known congenital anomalies or meconium stained fluid
- any woman with illnesses such as maternal fever, chorioamnionitis, severe neonatal distress
- any woman with compromised infant at delivery
- oligohydramnios
- history of antenatal steroids.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jack D. Weiler Hospital of the Albert Einstein College of Medicine
The Bronx, New York, 10461, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Orna Rosen, MD
Montefiore Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Asst Prof., Dept of Pediatrics (Neonatology)
Study Record Dates
First Submitted
March 4, 2011
First Posted
March 8, 2011
Study Start
September 1, 2006
Primary Completion
February 1, 2009
Study Completion
February 1, 2009
Last Updated
August 31, 2018
Record last verified: 2018-08